• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颈内动脉注射尿激酶对狒狒急性脑卒中模型的有益作用。

The beneficial effect of intracarotid urokinase on acute stroke in a baboon model.

作者信息

Del Zoppo G J, Copeland B R, Waltz T A, Zyroff J, Plow E F, Harker L A

出版信息

Stroke. 1986 Jul-Aug;17(4):638-43. doi: 10.1161/01.str.17.4.638.

DOI:10.1161/01.str.17.4.638
PMID:3738945
Abstract

The capacity of intracarotid infusion of urokinase to salvage neurologic function in a baboon model of acute thrombotic stroke has been studied. The model consists of reversible eccentric balloon compression (3 hours) of the right middle cerebral artery (MCA) proximal to the take-off of the lenticulostriate arteries (LSA), resulting in in situ thrombosis of perforating branches supplying the right corpus striatum. Neurologic endpoints included quantitative assessment of neurologic function (NE), estimation of cerebral infarction volume by computerized tomographic (CT) scan, and carotid angiography. In untreated acute stroke control animals (n = 6), a persistent decrease in functional score (from 100 to 36 +/- 11) at 14 days and a defined region of cerebral infarction (volume = 3.2 +/- 1.5) were detected at 10 days. Intracarotid urokinase administered to five animals (1.2 X 10(6) IU over 60 min) following the 3 hour period of MCA occlusion improved neurologic function (NE = 50, 55, 85, 100, 100) and reduced infarction size (0.3, 0.5, 0.8, 0.7, 1.1 cm3, respectively) without evidence of intracranial hemorrhage. Systemic fibrinogenolysis was produced in all five treated animals. We conclude that thrombolytic therapy given within 3 hours of experimental thrombotic occlusion may salvage neurologic function and reduce cerebral infarction volume without CT scan detectable intracranial bleeding.

摘要

已对在急性血栓性中风狒狒模型中,颈内动脉输注尿激酶挽救神经功能的能力进行了研究。该模型包括对豆纹动脉(LSA)起始部近端的右侧大脑中动脉(MCA)进行可逆性偏心球囊压迫(3小时),导致供应右侧纹状体的穿支动脉原位血栓形成。神经学终点包括神经功能的定量评估(NE)、通过计算机断层扫描(CT)估算脑梗死体积以及颈动脉血管造影。在未经治疗的急性中风对照动物(n = 6)中,在14天时功能评分持续下降(从100降至36±11),并且在10天时检测到明确的脑梗死区域(体积 = 3.2±1.5)。在MCA闭塞3小时后,对五只动物进行颈内动脉尿激酶给药(60分钟内给予1.2×10⁶ IU)改善了神经功能(NE分别为50、55、85、100、100)并减小了梗死面积(分别为0.3、0.5、0.8、0.7、1.1 cm³),且无颅内出血迹象。所有五只接受治疗的动物均出现全身纤维蛋白溶解。我们得出结论,在实验性血栓闭塞3小时内给予溶栓治疗可挽救神经功能并减小脑梗死体积,且CT扫描未检测到颅内出血。

相似文献

1
The beneficial effect of intracarotid urokinase on acute stroke in a baboon model.颈内动脉注射尿激酶对狒狒急性脑卒中模型的有益作用。
Stroke. 1986 Jul-Aug;17(4):638-43. doi: 10.1161/01.str.17.4.638.
2
Experimental acute thrombotic stroke in baboons.狒狒的实验性急性血栓性中风
Stroke. 1986 Nov-Dec;17(6):1254-65. doi: 10.1161/01.str.17.6.1254.
3
PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.PROACT:重组尿激酶经动脉直接给药治疗急性大脑中动脉卒中的II期随机试验。PROACT研究人员。急性脑血栓栓塞症中的普洛赛克(重组尿激酶)。
Stroke. 1998 Jan;29(1):4-11. doi: 10.1161/01.str.29.1.4.
4
Evaluation of reperfusion and recovery of brain function before and after intracarotid arterial urokinase therapy in acute cerebral infarction with brain SPECT.脑SPECT评估急性脑梗死患者颈内动脉注射尿激酶治疗前后脑血流灌注及脑功能恢复情况
Clin Nucl Med. 1999 Aug;24(8):566-71. doi: 10.1097/00003072-199908000-00004.
5
Fibrinolytic therapy for acute embolic stroke: intravenous, intracarotid, and intra-arterial local approaches.急性栓塞性中风的纤维蛋白溶解疗法:静脉、颈内动脉和动脉内局部治疗方法。
Neurosurgery. 1995 Feb;36(2):246-52; discussion 252-3. doi: 10.1227/00006123-199502000-00002.
6
Tissue-type plasminogen activator improves neurological functions in a rat model of thromboembolic stroke.组织型纤溶酶原激活剂可改善血栓栓塞性中风大鼠模型的神经功能。
Stroke. 1994 Feb;25(2):451-6. doi: 10.1161/01.str.25.2.451.
7
Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery.颈内动脉注射尿激酶治疗大脑中动脉血栓栓塞性闭塞
Stroke. 1988 Jul;19(7):802-12. doi: 10.1161/01.str.19.7.802.
8
Local intra-arterial fibrinolysis in acute hemispheric stroke: effect of occlusion type and fibrinolytic agent on recanalization success and neurological outcome.急性半球性卒中的局部动脉内纤维蛋白溶解疗法:闭塞类型和纤维蛋白溶解剂对再通成功率和神经功能结局的影响
Cerebrovasc Dis. 2003;15(4):258-63. doi: 10.1159/000069493.
9
Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits [corrected].动脉内注射组织型纤溶酶原激活剂和尿激酶对兔脑循环中自体动脉栓子的影响[校正后]
Stroke. 1990 Nov;21(11):1594-9. doi: 10.1161/01.str.21.11.1594.
10
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.急性缺血性卒中动脉内注射尿激酶原。PROACT II研究:一项随机对照试验。急性脑血栓栓塞症中的普洛激酶。
JAMA. 1999 Dec 1;282(21):2003-11. doi: 10.1001/jama.282.21.2003.

引用本文的文献

1
Comparison of Large Animal Models for Acute Ischemic Stroke: Which Model to Use?大动物急性缺血性脑卒中模型比较:应该选择哪种模型?
Stroke. 2022 Apr;53(4):1411-1422. doi: 10.1161/STROKEAHA.121.036050. Epub 2022 Feb 15.
2
Fifty Years of Acute Ischemic Stroke Treatment: A Personal History.《急性缺血性脑卒中治疗的五十年:个人史》
Cerebrovasc Dis. 2021;50(6):666-680. doi: 10.1159/000519843. Epub 2021 Oct 14.
3
Preclinical Stroke Research and Translational Failure: A Bird's Eye View on Preventable Variables.临床前卒中研究与转化失败:可预防变量的鸟瞰图。
Cell Mol Neurobiol. 2022 Oct;42(7):2003-2017. doi: 10.1007/s10571-021-01083-6. Epub 2021 Mar 30.
4
Urokinase Plasminogen Activator: A Potential Thrombolytic Agent for Ischaemic Stroke.尿激酶型纤溶酶原激活物:缺血性脑卒中的一种潜在溶栓药物。
Cell Mol Neurobiol. 2020 Apr;40(3):347-355. doi: 10.1007/s10571-019-00737-w. Epub 2019 Sep 24.
5
Thrombolytic Therapy for Acute Ischemic Stroke.急性缺血性脑卒中的溶栓治疗
Stroke. 2019 Sep;50(9):2597-2603. doi: 10.1161/STROKEAHA.119.025699. Epub 2019 Jul 22.
6
Experimental animal models and inflammatory cellular changes in cerebral ischemic and hemorrhagic stroke.脑缺血性和出血性卒中的实验动物模型及炎症细胞变化
Neurosci Bull. 2015 Dec;31(6):717-34. doi: 10.1007/s12264-015-1567-z. Epub 2015 Dec 2.
7
Experimental intracerebral hemorrhage: avoiding pitfalls in translational research.实验性脑出血:避免转化研究中的陷阱。
J Cereb Blood Flow Metab. 2011 Nov;31(11):2135-51. doi: 10.1038/jcbfm.2011.124. Epub 2011 Aug 24.
8
Thrombolytic therapy for acute stroke.急性中风的溶栓治疗。
West J Med. 1989 May;150(5):577.
9
Can the time window for administration of thrombolytics in stroke be increased?中风溶栓治疗的时间窗可以延长吗?
CNS Drugs. 2003;17(14):995-1011. doi: 10.2165/00023210-200317140-00001.
10
Thrombolysis in acute ischaemic stroke.急性缺血性卒中的溶栓治疗
Postgrad Med J. 2001 Mar;77(905):166-71. doi: 10.1136/pmj.77.905.166.